Caeregen Therapeutics LLC
Caeregen Therapeutics develops therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Caeregen is developing Noregen, a recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss.
Company Location
510 Meadowmont Village Circle, Suite 303
Chapel Hill
NC
27517
Phone
County
Region
Company Details
Company type
Year founded
2010
Employment range in NC
US headquarters
Michigan
Global headquarters
United States
Primary site activity
All company activities
Products under development
Noregen